Ergomar (Rosedale Therapeutics)


Welcome to the PulseAid listing for the Ergomar drug offered from Rosedale Therapeutics. This Ergotamine Derivative [EPC],Ergotamines [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Rosedale Therapeutics
NON-PROPRIETARY NAME: Ergotamine Tartrate
SUBSTANCE NAME: ERGOTAMINE TARTRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Ergotamine Derivative [EPC],Ergotamines [Chemical/Ingredient]
ROUTE: SUBLINGUAL
DOSAGE FORM: TABLET, ORALLY DISINTEGRATING
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2012-08-31
END MARKETING DATE: 0000-00-00


Ergomar HUMAN PRESCRIPTION DRUG Details:

Item DescriptionErgomar from Rosedale Therapeutics
LABELER NAME: Rosedale Therapeutics
DEA SCHEDULE:
ACTIVE STRENGTH: 2(mg/1)
START MARKETING DATE: 2012-08-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 10802-1202_6ac058ea-d4f4-4fcd-83e1-5f2adb8652e6
PRODUCT NDC: 10802-1202
APPLICATION NUMBER: ANDA087693

Other ERGOTAMINE TARTRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Rosedale TherapeuticsErgomar
TerSera Therapeutics, LLCErgomar